CD274 and neoplasm: In view of the importance of glycosylation in the functionality of PD-L1, strategies aimed at modulating this function have been deployed, in particular, with monoclonal antibodies, directed specifically against the glycosylated forms of PD-L1, whose anti-tumor action seems promising in preclinical models [62].